Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC)
Clinical trial NCT03766776 · UNKNOWN
Trial details
- NCT number
- NCT03766776
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-31
- Primary completion
- 2019-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.